Document Type : Original Article

Author

MSc Student of Operating Room Nursing, Student Research Committee, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran

Abstract

Background and aims: Prostate neoplasms have various geographical distribution in the world as well as in Iran. This study aimed to investigate the epidemiology of prostate neoplasms in Maragheh due to the lack of literature on the subject in this city.
Methods: This study is a descriptive-analytical, cross-sectional study in which the epidemiological status of prostate neoplasms was investigated in Maragheh during 2014-2019. All available records in the form of a census were included in the study. A checklist made by the researcher was used as a special tool for collecting data from prostate neoplasms medical records. The collected data were analyzed by statistical tests of chi-square, unpaired t test, Kruskal–Wallis test, and Cohen’s kappa coefficient using SPSS 25 software. 
Results: By way of explanation, 107 medical records on prostate neoplasms were recorded between 2014 and 2019. The mean and median ages were 71.33 ± 9.37 and 70 years. The highest frequency was observed in the 60-70 age group with a frequency of 41.1% (44 cases). All patients had been undergoing clinical examination (first) and pathological examination (after prostatectomy). For 12.1% of individuals, benign prostatic hyperplasia (BPH) had been diagnosed in the clinical diagnosis, and cancer and prostatitis had been diagnosed in the pathological test. Cohen’s kappa coefficient was obtained 20.4%, which was statistically significant (p ≤0001). The results showed a significant relationship between the number of prostate neoplasms and age groups (p ≤0001).
Conclusion: Taking the results of this study into account, it is recommended that more attention be paid to other laboratory and radiological tests such as the PSA test, ultrasound, etc. In addition to clinical examination, it is also suggested that screening programs be particularly developed for the age group ≥50 using a specific prostate antigen against this cancer.

Keywords

1.Haghshenas M, Golini-Moghaddam T, Rafiei A, Emadeian O, Shykhpour A, Ashrafi GH. Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer: a population-based study. Infect Agent Cancer. 2013;8(1):20. doi: 10.1186/1750-9378-8-20. 
2.Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, Enayatrad M, Salehiniya H. Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev. 2015;16(4):1409-13. doi: 10.7314/ apjcp.2015.16.4.1409. 
3.Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. 
4.Masoompour SM, Lankarani KB, Honarvar B, Tabatabaee SH, Moghadami M, Khosravizadegan Z. Changing epidemiology of common cancers in southern Iran, 2007- 2010: a cross sectional study. PLoS One. 2016;11(5):e0155669. doi: 10.1371/journal.pone.0155669. 
5.Amoori N, Mirzaei M, Cheraghi M. Incidence of cancers in Kuzestan province of Iran: trend from 2004 to 2008. Asian Pac J Cancer Prev. 2014;15(19):8345-9. doi: 10.7314/ apjcp.2014.15.19.8345. 
6.Hassanipour S, Fathalipour M, Salehiniya H. The incidence of prostate cancer in Iran: a systematic review and meta-analysis. Prostate Int. 2018;6(2):41-5. doi: 10.1016/j. prnil.2017.11.003. 
7.Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20(3):556-63. doi: 10.1093/ annonc/mdn642. 
8.Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. doi: 10.3322/ canjclin.55.2.74. 
9.Ghanavti M, Movahed M, Rashidkhani B, Rakhsha A, Hejazi E. Index-based dietary patterns and the risk of prostate cancer among Iranian men. Asian Pac J Cancer Prev. 2019;20(5):1393-401. doi: 10.31557/apjcp.2019.20.5.1393. 
10.McDaniel JT, Nuhu K, Ruiz J, Alorbi G. Social determinants of cancer incidence and mortality around the world: an ecological study. Glob Health Promot. 2019;26(1):41-9. doi: 10.1177/1757975916686913. 
11.Autorino R, Di Lorenzo G, Damiano R, Giannarini G, De Sio M, Cheng L, et al. Pathology of the prostate in radical cystectomy specimens: a critical review. Surg Oncol. 2009;18(1):73-84. doi: 10.1016/j.suronc.2008.07.006. 
12.Darves-Bornoz A, Park J, Katz, A. Prostate cancer epidemiology. In: Tewari AK, Whelan P, Graham JD, eds. Prostate Cancer: Diagnosis and Clinical Management. Vol 11. Wiley; 2014. p. 1-15. doi: 10.1002/9781118347379.ch1. 
13.Mallick S, Blanchet P, Multigner L. Prostate cancer incidence in Guadeloupe, a French Caribbean archipelago. Eur Urol. 2005;47(6):769-72. doi: 10.1016/j.eururo.2005.02.020. 
14.Lane JA, Donovan JL, Davis M, Walsh E, Dedman D, Down L, et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014;15(10):1109-18. doi: 10.1016/s1470-2045(14)70361-4. 
15.Rafiemanesh H, Enayatrad M, Salehiniya H. Epidemiology and trends of mortality from prostate cancer in Iran. J Isfahan Med Sch. 2015;33(330):1-7. [Persian]. 
16.Enayatrad M, Mirzaei M, Salehiniya H, Karimirad MR, Vaziri S, Mansouri F, et al. Trends in incidence of common cancers in Iran. Asian Pac J Cancer Prev. 2016;17(S3):39-42. doi: 10.7314/apjcp.2016.17.s3.39. 
17.McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol. 1978;15(4):340-5. 
18.Haghighi F, Habibi A, Tavakoli M. Epidemiologic retrospective study of neoplasms of prostate gland in Birjand (South Khorasan province). J Birjand Univ Med Sci. 2005;12(1):9-15. [Persian]. 
19.Falahatkar S, Atrkar Roshan Z, Askari SA, Shafaghi A, Bagherian M, Shekarchi K, et al. Prevalence of hidden prostate carcinoma. J Guilan Univ Med Sci. 2005;14(54):53- 8. [Persian]. 
20.Almasi A, Shamsi M, Eshrati B, Javaheri J, Salimi Alast S, Ghasemi Z, et al. Epidemiology of prostate cancer in Markazi province in 2005-2010. J Neyshabur Univ Med Sci. 2014;2(3):1-8. [Persian].